MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motor control"

  • 2025 International Congress

    Impact of ND0612 on Levodopa-Induced Dyskinesia in Parkinson’s Disease: Post hoc Analyses From a Randomized, Active-Controlled Study

    A. Ellenbogen, R. Pahwa, J. Hernández-Vara, N. Lopes, J. Pereira, A. Espay (Farmington Hills, USA)

    Objective: To evaluate dyskinesia-related outcomes between optimized subcutaneously administered levodopa/carbidopa (ND0612) + immediate-release levodopa/carbidopa (IR-LD/CD) vs optimized oral IR-LD/CD in patients with Parkinson’s disease (PD).…
  • 2025 International Congress

    Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

    F. Luna-Rangel, B. Gonzalez-Bedolla, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To assess the efficacy of virtual rehabilitation therapy compared to conventional physical therapy in patients with Parkinson’s disease. Background: Rehabilitation is essential in managing…
  • 2025 International Congress

    A Novel Quantitative Assessment to Evaluate Functional Impairment in Parkinson’s Disease

    V. Vanchinathan, M. Farah, A. Singh, C. Zhang, N. Osei-Owusu, R. Desai, R. Palani, J. Hamkins, M. Zwernemann, S. Grill, A. Pantelyat, J. Brašić (Baltimore, USA)

    Objective: To investigate if motion data collected from inertial measurement units (IMUs) mounted on implements used in activities of daily living (ADLs) can characterize the…
  • 2025 International Congress

    Opicapone in Parkinson’s Patients with Probable REM Sleep Behavior Disorder: Insights from the OASIS Trial

    J. Ferreira, M. Gago, R. Costa, M. Fonseca, H. Brigas, D. Magalhães, J. Holenz, C. Trenkwalder (Lisbon, Portugal)

    Objective: To evaluate opicapone’s effect on sleep disturbances, motor and non-motor symptoms and quality of life in Parkinson's disease (PD) patients with and without probable…
  • 2025 International Congress

    Validation of a quantitative test using kinesiological evaluation of upper extremity movements in patients with Parkinson’s disease: A pilot study.

    A. Castillo-Ivon, A. Montes-Ugalde, V. Bueyes-Roiz, C. Hernandez-Arenas, P. Velasco-Acosta, L. Anaya-Campos, I. Quiñones-Uriostegui, J. Quinzaños-Fresnedo (Mexico City, Mexico)

    Objective: To establish the validity of an upper extremity kinesiological assessment in patients with Parkinson's disease as a complementary tool to clinical instruments. Background: Parkinson's…
  • 2025 International Congress

    Embodying a Sixth Soft Finger. How Wearing a Supernumerary Robotic Digit Impacts our Body Schema

    J. Sykes, F. Genovese, G. Barchiesi, C. Sinigaglia (Milan, Italy)

    Objective: To assess whether a supernumerary robotic digit can enter into the user’s body schema, thereby altering bodily self-representation and proprioceptive awareness. Background: Stroke is…
  • 2025 International Congress

    Changes in Motor States Throughout the Waking Day With Tavapadon in People With Parkinson’s Disease

    R. Hauser, R. Pahwa, L. Harmer, A. Lind (Tampa, USA)

    Objective: To evaluate motor states throughout the waking day when adding tavapadon to oral carbidopa/levodopa in adults with Parkinson’s disease experiencing motor fluctuations. Background: Long-term…
  • 2025 International Congress

    Study on individual differences in shoulder and hip joints during walking in patients with Parkinson’s disease

    J. Ogawa, Y. Yamaguchi, K. Kakegawa, T. Matsuda, T. Kurayama (Ginza, Chuo-ku, Japan)

    Objective: To analyze the motion characteristics of the shoulder and hip joints during gait in people with Parkinson’s disease (PwP) and explore the classification of…
  • 2025 International Congress

    Advancing Hypomimia Assessment in Parkinson’s Disease by Integrating a Continuous Monitoring Device into Clinical Practice

    A. Wiederhold, C. Gundler (Hamburg, Germany)

    Objective: We aim to establish a robust, continuous method for monitoring hypomimia in Parkinson’s disease (PD), bridging the gap between sporadic clinical evaluations and real-life…
  • 2025 International Congress

    Heat Map Visualization of Improved Best ON Time in People With Parkinson’s Disease Treated With Foscarbidopa/Foslevodopa

    T. Henriksen, R. Hauser, I. Malaty, T. Kimber, M. Soileau, L. Bergmann, L. Harmer, J. Homola, R. Gupta, C. Yan, B. Bergmans (North Chicago, USA)

    Objective: Assess the impact of foscarbidopa/foslevodopa (CDp/LDp) continuous subcutaneous infusion (CSCI) on the motor states of people with Parkinson’s disease (PD) across 24 hours via…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley